The Utility of Laboratory Screening in Medically III Patients With Psychiatric Symptoms

References

• Sheline Y, Kehr C: Cost and utility of routine admission labo-ratory testing for psychiatric inpatients. Gen Hosp Psychiatry 1990; 12:329–334
   Google Scholar
• Anfinson TJ, Kathol RG: Screening laboratory evaluation in psychiatric patients: A review. Gen Hosp Psychiatry 1992; 14:248–257
   PubMed Web of Science ®Google Scholar
• Stott DJ, Langhorne P, Hendry A, McKay PJ, Holyoake T, Macdonald J, Lucie N: Prevalence and haemopoiectic effects of low serum vitamin B12 levels in geriatric medical patients. Brit J Nutr 1997; 78:57–63
   Google Scholar
• Martin DC, Francis J, Protetch J, Huff J: Time dependency of cognitive recovery with cobalamin replacement: Report of a pilot study. J Am Geriatr Soc 1992; 40:168–172
   PubMed Web of Science ®Google Scholar
• Domisse J: Subtle vitamin deficiency and psychiatry: A largely unnoticed but devastating relationship? Med Hypotheses 1991; 34:137–140
   Google Scholar
• O'Neill D, Barber RD: Reversible dementia caused by vitamin B12 deficiency. J Am Geriatr Soc 1993; 41:192–193
   PubMed Web of Science ®Google Scholar
• Catalano G, Catalano MC, Rosenberg El, Embi PJ, Embi CS: Catatonia: Another neuropsychiatric presentation of vitamin B12 deficiency? Psychosomatics 1998; 39:456–460
   PubMed Web of Science ®Google Scholar
• Newbold HL: Vitamin B12: Placebo or neglected therapeutic tool? Med Hypotheses 1989; 28: 155–164
   Google Scholar
• Smith ADM: Megaloblastic madness. BMJ 1960; 2:1840–1845
   PubMedGoogle Scholar
• Greenberg DB: Cobalamin deficiency. In: Rundell JR, Wise MG, eds. The American Psychiatric Press Textbook of Consultation-Liaison Psychiatry. Washington: American Psychiatric Press; 1996; 586
   Google Scholar
• VanTiggelen CJM, Peperkamp JPC, TerToolen JFW: Vitamin-B12 levels of cerebrospinal fluid in patients with organic mental disorder. J Orthomol Psychiatry 1983; 12:305–311
   Google Scholar
• Mitsuyama Y, Kogoh H: Serum and cerebrospinal fluid vitamin B12 levels in demented patients with CH3-B12 treatment—preliminary study. Jpn J Psychiatry Neurol 1988; 42:65–71
   PubMedGoogle Scholar
• Bottiglieri T: Folate, vitamin B12, and neuropsychiatric disor-ders. Nutr Rev 1996; 54:382–390
   PubMed Web of Science ®Google Scholar
• Bottiglieri T, Hyland K, Reynolds EH: The clinical potential of ademetionine (S-adenosylmethionine) in neurological dis-orders. Drugs 1994; 48:137–152
   PubMed Web of Science ®Google Scholar
• Fava M, Borus JS, Alpert JE, Nierenberg AA, Rosenbaum JF, Bottiglieri T: Folate, vitamin B12, and homocysteine in major depressive disorder. Am J Psychiatry 1997; 154:426–428
   PubMed Web of Science ®Google Scholar
• Wesson VA, Levitt AJ, Joffe RT: Change in folate status with antidepressant treatment. Psychiatry Res 1994; 53:313–322
   PubMed Web of Science ®Google Scholar
• Greenberg DB: Fatigue. In: Rundell JR, Wise MG, eds. The American Psychiatric Press Textbook of Consultation-Liaison Psychiatry. Washington: American Psychiatric Press; 1996; 587–594
   Google Scholar
• Van Gorp WG, Cummings JL: Neuropsychiatric aspects of infectious disorders. In: Kaplan HI, Sadock BJ, eds. Comprehensive Textbook of Psychiatry. Baltimore: Williams & Wilkins; 1995; 235–241
   Google Scholar
• Kaplan HI, Sadock RP Kaplan and Sadock's Synopsis of Psy-chiatry Behavioral Sciences/Clinical Psychiatry, 8th edn. Bal-timore: Williams & Wilkins; 1998
   Google Scholar
• Tappy L, Randin JP, Schwed P, Wertheimer J, Lemarchand-Beraud T: Prevalence of thyroid disorders in psychogeriatric inpatients: A possible relationship of hypothyroidism with neurotic depression but not with dementia. J Am Geriatr Soc 1987; 35:526–531
   PubMedGoogle Scholar
• Stern RA, Prange AJ: Neuropsychiatric aspects of endocrine disorders. In: Kaplan HI, Sadock BJ, eds. Comprehensive Text-book of Psychiatry. Baltimore: Williams & Wilkins; 1995; 241–251
   Google Scholar
• Robertson KR, Stern RA, Hall CD, Perkins DO, Wilkins JW, Gortner DT, Donovan K, Messenheimer JA, Whaley R, Evans DL: Vitamin B12 deficiency and nervous system disease in HIV infection. Arch Neurol 1993; 50:807–811
   Google Scholar
• Teunisse S, Bonen AE, van Gool WA, Walstra GJM: Dementia and subnormal levels of B12: Effects of replacement therapy on dementia. J Neuro11996; 243:522–529
   Web of Science ®Google Scholar
• Crystal HA, Ortof E, Frishman WH, Gruber A, Hershman D, Aronson M: Serum vitamin B12 levels and incidence of dementia in a healthy elderly population: A report from the Bronx longitudinal aging study. J Am Geriatr Soc 1994; 42:933–936
   PubMed Web of Science ®Google Scholar
• Naughton BJ, Moran MB: Patterns of syphilis testing in the elderly. J Gen Intern Med 1992; 7:273–275
   Google Scholar
• Ryan WG, Roddam RF, Grizzle WE: Thyroid function screening in newly admitted psychiatric inpatients. Ann Clin Psychiatry 1994; 6:7–12
   PubMedGoogle Scholar
• White AJ, Barraclough B: Benefits and problems of routine laboratory investigations in adult psychiatric admissions. Br J Psychiatry 1989; 155:65–72
   PubMed Web of Science ®Google Scholar
• Mookhoek EJ, Sterrenburg-v.d.Nieuwegiessen IM: Screening for somatic disease in elderly psychiatric patients. Gen Hosp Psychiatry 1998; 20:102–107
   Google Scholar
• Brett AS, Roberts MS: Screening for vitamin B12 defi-ciency in psychiatric patients. J Gen Intern Med 1994; 9:522–524
   PubMedGoogle Scholar
• Romfh RF: The appropriateness of routine diagnostic studies. Mil Med 1898; 54:140–144
   Google Scholar
• Adams M, Kutcher S, Antoniw E, Bird D: Diagnostic utility of endocrine and neuroimaging screening tests in first-onset adolescent psychosis. J Am Acad Child Adolesc Psychiatry 1996; 35:67–73
   Google Scholar
• Greenberg PE, Stiglin LE, Finkelstein SN, Berndt ER: De-pression: A neglected major illness. J Clin Psychiatry 1993; 54:419–426
   PubMed Web of Science ®Google Scholar
• Kaplan HI, Sadock BJ: Synopsis of Psychiatry. Baltimore: Williams & Wilkins; 1998
   Google Scholar